I now have comprehensive material. Let me compile a thorough, well-organized response.
Low WBC with Fever (Febrile Neutropenia)
Definition
Febrile neutropenia (FN) is defined as:
- Fever: temperature ≥38.3°C (100.9°F) on one occasion, OR ≥38.0°C (100.4°F) persisting >1 hour
- Neutropenia: Absolute Neutrophil Count (ANC) <1000/mm³
Severity grading:
| Grade | ANC |
|---|
| Neutropenia | <1000/mm³ |
| Severe neutropenia | <500/mm³ |
| Profound neutropenia | <100/mm³ |
Empiric antibiotics are most clearly indicated at ANC ≤500/mm³. Between 500-1000/mm³, clinical judgment and other risk factors guide the decision. - Tintinalli's Emergency Medicine, p. 1559
Why It's a Medical Emergency
The lack of neutrophils cripples the inflammatory response, which means:
-
Classic signs of infection (pus, induration, infiltrates on CXR) may be absent or minimal
-
Fever may be the only sign of a life-threatening infection
-
Some patients (on steroids, post-BMT, elderly) may not even mount a fever - they may instead show unexplained tachycardia, tachypnea, altered mental status, metabolic acidosis, or hyperglycemia
-
Rosen's Emergency Medicine, p. 1432
Causes of Neutropenia
Most common: chemotherapy (nadir typically 5-10 days after the last dose, recovery within 5 days)
Other causes include:
-
Medications: antithyroids (methimazole, PTU), penicillins, chloramphenicol, sulfasalazine, anticonvulsants (valproate, carbamazepine), procainamide
-
Bone marrow failure/infiltration (leukemia, aplastic anemia, myelodysplasia)
-
Congenital neutropenias (e.g., Kostmann syndrome)
-
Viral infections (HIV, parvovirus B19, EBV)
-
Autoimmune (e.g., SLE, Felty syndrome)
-
Quick Compendium of Clinical Pathology, p. 8889
Key Pathogens
Pseudomonas aeruginosa must always be covered empirically - it is the organism whose omission carries the highest mortality risk. Other important pathogens include:
- Gram-negatives: E. coli, Klebsiella, Enterobacter
- Gram-positives: Staphylococcus aureus (MRSA), Streptococcus species, coagulase-negative staph (line infections)
- Fungi: Candida (especially in prolonged neutropenia), Aspergillus
Disseminated fungal infections may present with characteristic skin lesions - ecthyma gangrenosum (a "bull's-eye" necrotic lesion) is the classic finding in P. aeruginosa bacteremia. - Goldman-Cecil Medicine, p. 4028
Evaluation
History:
- Chemotherapy regimen and last dose date
- Presence/type of indwelling catheters (central lines, ports)
- Recent antibiotics or prophylaxis (fluoroquinolone use changes antibiotic selection)
- Bone marrow transplant status, corticosteroid use
Physical Examination - three areas not to miss:
- Oral cavity - mucositis, thrush, ulcers
- Perianal area - tenderness (may be the only sign of perirectal abscess); digital rectal exam is contraindicated until after first antibiotic dose
- IV catheter sites - redness, tenderness, discharge
Workup:
- Two blood cultures (one peripheral, one from central catheter if present)
- Urinalysis + urine culture
- Chest radiograph (note: infiltrates may be absent even in pneumonia)
- CBC with differential, electrolytes, renal and hepatic function
- Sputum, wound, or stool cultures only if clinically indicated
Note: Rectal temperature measurement is contraindicated in neutropenic patients (theoretical risk of bacterial translocation). - Tintinalli's Emergency Medicine, p. 1558
Risk Stratification
Use the MASCC (Multinational Association for Supportive Care in Cancer) Risk Index or the CISNE (Clinical Index of Stable Febrile Neutropenia) score to categorize patients:
High-risk (requires hospitalization) - any of the following:
- Profound neutropenia expected to last >7 days
- Significant comorbidities (poorly controlled COPD, diabetes, heart failure)
- Acute liver or renal injury
- Hemodynamic instability / signs of sepsis
- Non-low-risk MASCC or CISNE score
Low-risk (may consider outpatient treatment):
-
Looks well, no abdominal pain, no localizing signs of infection
-
Normal chest radiograph
-
Neutropenia expected to resolve within 7 days
-
Daily follow-up by a medical provider must be available
-
Tintinalli's Emergency Medicine, p. 1559
Treatment: Empiric Antibiotics
| Situation | Regimen | Notes |
|---|
| Outpatient (low-risk) | Ciprofloxacin 500 mg PO q12h + Amoxicillin-clavulanate 875/125 mg PO q8h | OR Levofloxacin 750 mg PO daily + Clindamycin 300 mg PO q8h |
| Inpatient monotherapy | Piperacillin-tazobactam 4.5g IV q6h OR Cefepime 2g IV q8h OR Ceftazidime 2g IV q8h OR Meropenem 1g IV q8h | Use carbapenem if known ESBL colonization |
| Add vancomycin | Vancomycin 1g IV q12h | If: hemodynamic instability, catheter infection, cellulitis, known MRSA colonization, severe mucositis with prior fluoroquinolone use |
| Add metronidazole | 500 mg IV q6h | If abdominal symptoms present |
Monotherapy is as effective as dual therapy in most patients without specific risk factors. - Tintinalli's Emergency Medicine, p. 1559
Timing: Antibiotics should be given immediately - within the first hour. Delay significantly worsens mortality in febrile neutropenia.
Special Populations
Pediatric patients: Same general approach, but hematology should be consulted for first episodes or if heritable neutropenia is suspected. - Tintinalli's Emergency Medicine, p. 1308
Post-BMT / corticosteroid users: These patients may not mount fever; monitor for subtle signs of infection. Infectious causes AND noninfectious causes (drug toxicity, transfusion reaction, pulmonary emboli) must be considered.
Common Pitfalls to Avoid
- Assuming no infection because the patient is afebrile (some patients cannot mount fever)
- Missing perianal/oral/catheter-site infections on exam
- Performing rectal temperature measurement or digital rectal exam before antibiotics
- Over-relying on lab findings (no pyuria in UTI, no infiltrate on CXR in pneumonia)
- Misinterpreting leukocytosis after G-CSF as reassuring - these patients still need full FN evaluation
- Delaying antibiotics while awaiting culture results
- Rosen's Emergency Medicine, p. 1434
Recent Evidence
Two recent systematic reviews are worth noting:
- A 2023 systematic review (PMID: 37921996) supports ambulatory management of low-risk FN as safe and effective in selected adult oncology patients.
- A 2025 meta-analysis (PMID: 40079575) found that early antibiotic de-escalation in hematologic malignancy patients with FN is both efficacious and safe, supporting shorter broad-spectrum courses once cultures and clinical response allow.
These align with and reinforce current textbook guidance.